A Discussion with Linda Sullivan and Laurie Halloran on Now Is the Time: Making Your Clinical Trial More Resilient

July 24, 2020
 

 

 

About this episode:

In this episode, host Linda Sullivan, MBA, Executive Director of WCG's Metric Champion Consortium (MCC) chats with Laurie Halloran, founder of the Halloran Consulting Group, about how she developed an on-demand drug development team that can fill in gaps in the clinical trial process for life science companies, whether these involve regulatory strategy or execution, or quality, clinical, or manufacturing issues. The COVID-19 pandemic has resulted in these companies having to pivot to more virtual experiences. At the beginning of the outbreak, she notes, her group organized town halls that made it clear to stakeholders that life science companies had to implement telehealth and other remote monitoring solutions to protect patient safety. As a result of the pandemic, Halloran explains, her group is reviewing clinical trial protocols to determine how technology can be better utilized in the collection of clinical trial data. In conclusion, Halloran says, “don’t waste this opportunity” to make your clinical trial program more resilient.

Interested in attending the MCC Clinical Trial Risk and Performance Management vSummit September 8-10? Visit https://www.centerwatch.com/mcc-summit-2020.

If you subscribe to this podcast, you can use the code POD15 to receive 15% off your registration fee.

 

Previous Post
Lisa Carlton, PhD: Fighting Rare Diseases as a Mother, Patient Advocate and Regulatory Affairs Professional
Lisa Carlton, PhD: Fighting Rare Diseases as a Mother, Patient Advocate and Regulatory Affairs Professional

Next Post
Hong Liu, PhD, Making Chicago a Healthier City for Asian Americans
Hong Liu, PhD, Making Chicago a Healthier City for Asian Americans